Clinical Trial Update: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of SKI2670 in endometriosis, with study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• SKI2670

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Endometriosis | Phase 1 | Status: COMPLETED